Millennium Pharmacon (Indonesia) Performance

SDPC Stock  IDR 144.00  1.00  0.69%   
The company secures a Beta (Market Risk) of 0.64, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Millennium Pharmacon returns are expected to increase less than the market. However, during the bear market, the loss on holding Millennium Pharmacon will be expected to be smaller as well. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Millennium Pharmacon has an expected return of -0.21%. Please make sure to verify Millennium Pharmacon International treynor ratio, value at risk, skewness, as well as the relationship between the maximum drawdown and potential upside to decide if Millennium Pharmacon performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Millennium Pharmacon International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Begin Period Cash Flow48.1 B
Total Cashflows From Investing Activities-4.2 B
  

Millennium Pharmacon Relative Risk vs. Return Landscape

If you would invest  16,300  in Millennium Pharmacon International on December 20, 2023 and sell it today you would lose (1,900) from holding Millennium Pharmacon International or give up 11.66% of portfolio value over 90 days. Millennium Pharmacon International is generating negative expected returns and assumes 1.3492% volatility on return distribution over the 90 days horizon. Simply put, 11% of stocks are less volatile than Millennium, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Millennium Pharmacon is expected to under-perform the market. In addition to that, the company is 2.39 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.23 per unit of volatility.

Millennium Pharmacon Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Millennium Pharmacon's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Millennium Pharmacon International, and traders can use it to determine the average amount a Millennium Pharmacon's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1573

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSDPC

Estimated Market Risk

 1.35
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.21
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.16
  actual daily
0
Most of other assets perform better
Based on monthly moving average Millennium Pharmacon is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Millennium Pharmacon by adding Millennium Pharmacon to a well-diversified portfolio.

Millennium Pharmacon Fundamentals Growth

Millennium Stock prices reflect investors' perceptions of the future prospects and financial health of Millennium Pharmacon, and Millennium Pharmacon fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Millennium Stock performance.

About Millennium Pharmacon Performance

To evaluate Millennium Pharmacon Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Millennium Pharmacon generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Millennium Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Millennium Pharmacon market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Millennium's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.

Things to note about Millennium Pharmacon performance evaluation

Checking the ongoing alerts about Millennium Pharmacon for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Millennium Pharmacon help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Millennium Pharmacon generated a negative expected return over the last 90 days
Millennium Pharmacon has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24.
Roughly 88.0% of the company outstanding shares are owned by corporate insiders
Evaluating Millennium Pharmacon's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Millennium Pharmacon's stock performance include:
  • Analyzing Millennium Pharmacon's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Millennium Pharmacon's stock is overvalued or undervalued compared to its peers.
  • Examining Millennium Pharmacon's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Millennium Pharmacon's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Millennium Pharmacon's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Millennium Pharmacon's stock. These opinions can provide insight into Millennium Pharmacon's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Millennium Pharmacon's stock performance is not an exact science, and many factors can impact Millennium Pharmacon's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.